Oridonin inhibits SARS-CoV-2 replication by targeting viral proteinase and polymerase
Description
COVID-19 has become a global public health crisis since its outbreak in China in December 2019. Currently there are few clinically effective drugs to combat SARS-CoV-2 infection. The main protein (M^(pro)), papain-like protease (PLpro) and RNA
